Role of glutamate in schizophrenia: integrating excitatory avenues of research.
about
The schizophrenia susceptibility gene dysbindin controls synaptic homeostasisRIM1alpha and interacting proteins involved in presynaptic plasticity mediate prepulse inhibition and additional behaviors linked to schizophreniaGroup II Metabotropic Glutamate Receptors as Targets for Novel Antipsychotic DrugsmGlu2 Receptor Agonism, but Not Positive Allosteric Modulation, Elicits Rapid Tolerance towards Their Primary Efficacy on Sleep Measures in RatsGenetic assessment of additional endophenotypes from the Consortium on the Genetics of Schizophrenia Family Study.Analysis of 94 candidate genes and 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia.A reappraisal of the association between Dysbindin (DTNBP1) and schizophrenia in a large combined case-control and family-based sample of German ancestryGlutamatergic gene expression is specifically reduced in thalamocortical projecting relay neurons in schizophrenia.Schizophrenia susceptibility and NMDA-receptor mediated signalling: an association study involving 32 tagSNPs of DAO, DAOA, PPP3CC, and DTNBP1 genes.Neuroanatomical, neurochemical, and neurodevelopmental basis of obsessive-compulsive symptoms in schizophreniaThe psychiatric disease risk factors DISC1 and TNIK interact to regulate synapse composition and function.Neuronal damage and protection in the pathophysiology and treatment of psychiatric illness: stress and depression.Association Study of N-Methyl-D-Aspartate Receptor Subunit 2B (GRIN2B) Polymorphisms and Schizophrenia Symptoms in the Han Chinese Population.Sex differences in GABAergic gene expression occur in the anterior cingulate cortex in schizophrenia.Repressive epigenetic changes at the mGlu2 promoter in frontal cortex of 5-HT2A knockout mice.Group II metabotropic glutamate receptors and schizophrenia.Drugs in development for the treatment of schizophrenia.Dynamics of glutamatergic signaling in the mushroom body of young adult Drosophila.Calcyon upregulation in adolescence impairs response inhibition and working memory in adulthood.Optimizing the glutamatergic challenge model for psychosis, using S+ -ketamine to induce psychomimetic symptoms in healthy volunteers.Recent advances in psychoneuroimmunology: Inflammation in psychiatric disorders
P2860
Q24632783-D4A4182A-151B-4ADC-BE13-B3A163C60346Q26269908-86D297BC-9AFC-4650-B0FE-7DB145691E0FQ26744729-A6437FEB-AF4E-4EF2-8392-9E46462C4963Q28551598-2D8F0DD6-A800-47AF-916A-A7566018CCEDQ30367047-3FCFB51E-1FAD-4B74-8D19-571F21548530Q30450376-A357C07B-A293-45F0-946F-ABFC42B7E8E4Q33798551-361990E9-C6B9-44F2-801E-0BBB9363CC7CQ33891806-8076B76E-007A-47E4-9FD4-5D5A46BEFBD8Q34623618-686FE6BC-B3CD-4148-982B-EEC9DC4BEAA4Q35199610-AB58D0A2-A628-492F-B3BE-B8FE7840C070Q35223834-756CD01E-F87D-455E-A258-DF9F49FE1643Q35237104-9B4913A6-7E1B-457C-B754-A6F9041440A8Q35644834-7CC157B7-7736-4EC1-AF4F-16B0BE791694Q35915861-D0BB166D-5692-4C71-B2F1-11277766CDB9Q36852536-9C43408D-5F76-4175-A012-5E86B5D748F9Q37473779-CF228A40-7C65-45EB-9041-265B644732A7Q37546125-74CF478B-F5CC-450E-9051-877F6950C928Q41194711-0BAF203E-471D-4810-9A55-169144515BC2Q41534671-1B23AF65-F1FF-4476-B939-FB9DD89FD8E5Q47746221-15FC0983-0504-4E4E-93BB-1A8F6DA26EADQ57844416-3FFE8B1B-403B-4E81-BE96-CADF98C4BE6D
P2860
Role of glutamate in schizophrenia: integrating excitatory avenues of research.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Role of glutamate in schizophrenia: integrating excitatory avenues of research.
@en
Role of glutamate in schizophrenia: integrating excitatory avenues of research.
@nl
type
label
Role of glutamate in schizophrenia: integrating excitatory avenues of research.
@en
Role of glutamate in schizophrenia: integrating excitatory avenues of research.
@nl
prefLabel
Role of glutamate in schizophrenia: integrating excitatory avenues of research.
@en
Role of glutamate in schizophrenia: integrating excitatory avenues of research.
@nl
P2860
P1476
Role of glutamate in schizophrenia: integrating excitatory avenues of research
@en
P2093
James Meador-Woodruff
Kimberly H Wood
P2860
P304
P356
10.1586/14737175.8.9.1389
P50
P577
2008-09-01T00:00:00Z